33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Apalutamide + abiraterone + leuprolide with stereotactic, ultra-hypofractionated radiation (AASUR) in very high risk prostate cancer (PCa)
    Meeting Abstract

    McBride, S. M.; Zelefsky, M. J.; Spratt, D. E.; Kollmeier, M.; Slovin, S. F.; Aghalar, J.; Hearn, J. W.; Den, R. B.; Deville, C.; Borofsky, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)
    Meeting Abstract

    McArthur, H. L.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Kallman, C.; D'Agnolo, A.; Rodine, M.; Arnold, B.; Zhang, Z. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with combined anti-CTLA4 + anti-PD1
    Meeting Abstract

    McQuade, J. L.; Warner, A. B.; Li, M. M.; Chon, J.; Haydu, L. E.; Daniel-MacDougall, C.; Hess, K. R.; Johnson, D. B.; Menzies, A. M.; Davies, M. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pharmacodynamic and clinical activity of RGX-104, a first-in-class immunotherapy targeting the liver-X nuclear hormone receptor (LXR), in patients with refractory malignancies
    Meeting Abstract

    Mita, M. M.; Mita, A. C.; Chmielowski, B.; Hamilton, E. P.; Pant, S.; Waltzman, R. J.; Rowinsky, E. K.; Szarek, M.; Gonsalves, F.; Kurth, I.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Transcriptional and post-transcriptional regulation of ribonucleotide reductase (RRM2) control its oncogenic role in prostate cancer progression
    Meeting Abstract

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Gerke, T. A.; Atiq, M. O.; Stopsack, K. H.; Komura, K.; Lee, G. S. M.; Mucci, L. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Inherited mutations in breast cancer patients with and without multiple primary cancers
    Meeting Abstract

    Maxwell, K. N.; Vijai, J.; Lilyquist, J.; Slavin, T. P.; Kulkarni, A.; Vaccaro, O.; Wubbenhorst, B.; Neuhausen, S. L.; Hart, S.; Ravichandran, V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neutropenia and response to single agent palbociclib
    Meeting Abstract

    McAndrew, N. P.; Dickson, M. A.; Clark, A. S.; Troxel, A.; Colameco, C.; Gallagher, M.; Gramlich, K.; Zafman, K.; Vaughn, D. J.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Is hospital patient safety culture relevant?
    Meeting Abstract

    Masciale, J. N.; Samedy, P.; Ogden, S.; Brauer, S.; Sepkowitz, K.; Granovsky, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Physicians' documented performance of shared decision-making with chronic lymphocytic leukemia patients
    Meeting Abstract

    Mato, A. R.; Davids, M. S.; Carter, J. D.; Greene, L.; Sapir, T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save